Duane Hassane

Duane Hassane is a senior director and head of Translational Omics in Hematology R&D at AstraZeneca since April 2024, concurrently serving as an assistant professor of Computational Biomedicine at Weill Cornell Medicine. With a rich background in oncology and hematology, Duane previously held positions as a strategic advisor at Zero-to-One and vice president at Tempus AI, driving precision medicine initiatives and genomic data application in translational studies. Duane's extensive experience at Weill Cornell Medicine includes directing leukemia genomics, developing molecular profiling strategies, and conducting pioneering research in early detection of acute myeloid leukemia. Educational qualifications include a Ph.D. in Microbiology, Immunology, and Molecular Genetics from the University of Kentucky and postdoctoral studies in cancer genomics at the University of Rochester.